TO THE MARKET
Series A in 2021
TO THE MARKET is a U.S.-based company founded in 2016 that specializes in the manufacturing and sourcing of ethical and sustainable apparel, accessories, and home goods. The company focuses on providing solutions that ensure transparency and responsibility within the supply chain. It serves artisan groups and suppliers globally, offering services that include design, production, compliance, sourcing, logistics, and reporting. TO THE MARKET employs a proprietary software platform that evaluates and monitors suppliers, allowing clients to access quantifiable data for responsible vendor compliance and management. This platform supports retailers in their sustainability initiatives by delivering automated reporting and procurement workflows, thus addressing the growing demand for operational transparency in the industry.
TO THE MARKET
Seed Round in 2019
TO THE MARKET is a U.S.-based company founded in 2016 that specializes in the manufacturing and sourcing of ethical and sustainable apparel, accessories, and home goods. The company focuses on providing solutions that ensure transparency and responsibility within the supply chain. It serves artisan groups and suppliers globally, offering services that include design, production, compliance, sourcing, logistics, and reporting. TO THE MARKET employs a proprietary software platform that evaluates and monitors suppliers, allowing clients to access quantifiable data for responsible vendor compliance and management. This platform supports retailers in their sustainability initiatives by delivering automated reporting and procurement workflows, thus addressing the growing demand for operational transparency in the industry.
Ocuphire Pharma
Seed Round in 2019
Ocuphire Pharma, Inc. is a clinical-stage biopharmaceutical company based in Farmington Hills, Michigan, dedicated to developing and commercializing therapies for various ophthalmic disorders. The company's primary focus is on innovative treatment options for front and back of the eye conditions, with its lead product candidate, Nyxol eye drops, currently in Phase 3 clinical development. Nyxol is a once-daily, preservative-free formulation aimed at addressing issues such as dim light or night vision disturbances, pharmacologically-induced mydriasis, and presbyopia. Additionally, Ocuphire is advancing another candidate, APX3330, a twice-daily oral tablet, which is entering Phase 2 clinical trials to target diabetic retinopathy and diabetic macular edema by inhibiting angiogenesis and inflammation. The company also seeks to explore opportunities for acquiring additional ophthalmic assets and forming strategic partnerships for global commercialization.
Vyv, formerly known as Vital Vio, Inc., is a company based in Troy, New York, that specializes in the design, engineering, and manufacturing of advanced antimicrobial lighting systems branded as VioSafe. Founded in 2012, Vyv offers a range of products, including under cabinet lights, T8 replacement bulbs, and various LED luminaires, all engineered to continuously combat germs and infectious pathogens. These innovative lighting solutions are utilized in diverse commercial settings such as hospitals, laboratories, food storage facilities, and educational institutions, aiming to enhance infection control and promote public health. Vyv's technology leverages visible light to disrupt the cell membranes of harmful microorganisms, effectively reducing their presence in environments where hygiene is critical. The company's clientele includes prominent institutions like Duke University and UCLA Health, underscoring its commitment to providing safe and effective lighting solutions across various sectors.
Joylux, Inc. is a health and wellness company based in Seattle, Washington, specializing in women's health solutions. Founded in 2013, the company develops LED-focused medical devices aimed at addressing pelvic-floor issues and enhancing vaginal health. Joylux offers an at-home pelvic-floor toning and vaginal rejuvenation device that employs photobiomodulation technology to alleviate symptoms associated with genitourinary syndrome of menopause. The company is dedicated to providing noninvasive, effective, and affordable products that improve various aspects of women's intimate health, while also focusing on collecting health data to help women better predict and manage their symptoms during menopause.
Digsite
Seed Round in 2015
Digsite, Inc. is a Madison, Wisconsin-based company that offers a software-as-a-service (SaaS) platform designed for online insight communities, enhancing traditional online focus group methodologies. Founded in 2014, Digsite's platform allows moderators to initiate discussions, upload multimedia content, and utilize various tools for surveys and feedback, enabling participants to contribute their insights effectively. The platform is tailored for marketers and researchers, facilitating rapid engagement with consumers to refine product concepts, marketing strategies, and customer experiences. By leveraging a familiar social media-style interface, Digsite enables the quick recruitment of participants and the establishment of research communities, significantly streamlining the qualitative research process. Additionally, its SmartReporting feature transforms qualitative findings into actionable insights, empowering businesses to make informed decisions swiftly.
Cardialen
Series B in 2015
Cardialen, Inc. is a medical device company based in Minneapolis, Minnesota, that specializes in developing innovative therapies for heart arrhythmias, particularly atrial fibrillation. Founded in 2008, the company focuses on creating implantable devices that provide low-energy, pain-free cardioversion therapies to restore normal heart rhythm. These devices utilize a proprietary technology that delivers a sequential series of low-voltage pulses to effectively address atrial fibrillation and other related conditions, such as rapid ventricular tachycardia and ventricular fibrillation, while minimizing patient discomfort and protecting heart tissue from damage. By targeting significant unmet medical needs, Cardialen aims to improve the quality of life for individuals suffering from these heart conditions.
Current Motor
Series A in 2011
Current Motor Company is an Ann Arbor, Michigan-based manufacturer specializing in electric motor scooters designed for urban commuters. The company develops and produces all-electric maxi-scooters that are zero-emission and environmentally friendly, catering to the growing demand for sustainable transportation solutions. Current Motor's scooters can reach speeds of up to 70 MPH and offer a range of approximately 50 miles on a single charge, utilizing standard household outlets for recharging. The company has established a strategic partnership with Dakkota Integrated Systems and sells its products through a network of dealers. In addition to scooters, Current Motor also manufactures electric hub motors and solar charging stations, further enhancing its commitment to energy-independent transportation options.